Roche Diagnostics India receives the Frost & Sullivan 2021 India Competitive Strategy Leadership Award

    Home / Business Markets / Roche Diagnostics India receives the Frost & Sullivan 2021 India Competitive Strategy Leadership Award

Roche Diagnostics India receives the Frost & Sullivan 2021 India Competitive Strategy Leadership Award

0

Its technology-centric solutions enable hospitals to improve operational efficiency and enable faster clinical decision making

MUMBAI, India, March 14, 2022 / PRNewswire / – Based on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan acknowledges Roche diagnostics India with the India Competitive Strategy Leadership Award 2021 for its well-executed national strategies, effective market penetration and innovative offerings.

Indian In Vitro Diagnostics Competitive Strategic Leadership Award 2021

Indian In Vitro Diagnostics Competitive Strategic Leadership Award 2021

Each year, Frost & Sullivan presents this award to the company that leverages competitive intelligence to successfully execute a strategy that results in stronger market share, competitive brand positioning and customer satisfaction.

Roche Diagnostics has gained a foothold in the fragmented Indian market by strategically targeting underdeveloped cities. Its technology-based solutions have significantly improved operational efficiency, quality of results and lead times to deliver exceptional value to diverse stakeholders.

“While other global market participants are reluctant to enter India’s price-sensitive IVD industry, Roche Diagnostics has strategically separated and introduced its latest products and technologies into distinct segments, penetrating and shaping the country’s IVD space.” , said Ojaswi Rana, a best practice research analyst for Frost & Sullivan. “By prioritizing market share over profitability, it specifically addressed the needs of Tier II and Tier III cities, thereby accelerating access to diagnostics in the country. Its model includes warehouses in different parts of the country. India to provide easier access to customers instead of creating a consolidated warehouse. “

As one of the largest R&D funders in the industry, Roche Diagnostics has a robust end-to-end diagnostic portfolio globally. It provides blood safety, clinical chemistry, complementary diagnostics, custom biotechnology, laboratory automation and molecular diagnostics software solutions and services. Roche also offers HPV DNA tests to detect the likelihood of cervical cancer, enabling patients to receive prompt treatment and prevent its progression.

In 2021, the company’s advanced laboratory automation systems conducted 350 million tests in India. Its next-generation instrument system, cobas® pure integrated solutions, combines immunoassays, clinical chemistry and ion concentration measurement on a single platform, enabling laboratories and hospitals to simplify daily operations. The compact analyzer performs up to 870 tests per hour and provides access to the complete clinical chemistry and immunochemistry test menu, including more than 230 diagnostic tests for COVID-19, ICU, oncology, endocrinology and cardiology from a single test tube.

“Roche is committed to reliable and accurate results and has focused on improving operational efficiency by training diagnostic professionals. To date, it has conducted more than 1,150 training sessions for Indian employees of hospitals, laboratories and blood banks. In addition, has invested in a call center service, smart center, digital applications (apps) and a force in the field to ensure maximum uptime, “noted Rana. “Its customer prioritization, superior customer experience and strong brand power are testament to its undisputed competitive leadership in the Indian market.”

The Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding results and superior performance in areas such as leadership, technology innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and in-depth secondary research to identify best practices in the industry.

About Frost & Sullivan
For six decades, Frost & Sullivan has been known around the world for its role in helping investors, business leaders and governments address economic change and identify disruptive technologies, Mega Trends, new business models and companies to act. resulting in a continuous stream of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.

Contact:
Tarini Singh
P: + 91-20 6718 9725
AND: Tarini.Singh@frost.com

About Roche Diagnostics India
Roche is the largest biotech company in the world. Roche Diagnostics is a world leader in IVD and Roche Diagnostics India is the market leader in IVD India, with over 9000 instrumental instruments. Roche Diagnostics’ broad range of innovative tests and diagnostics plays a pivotal role in the revolutionary area of ​​integrated healthcare solutions and covers early diagnosis, targeted screening, disease assessment and monitoring. Roche Diagnostics India works with the goal of “Doing now what patients need in the future”, thus preparing for the nation’s future healthcare needs.

All trademarks used or mentioned in this version are protected by law.

Contact:
Manjira Sharma
AND: manjira.sharma@roche.com

SOURCE Frost & Sullivan

Leave a Reply

Your email address will not be published. Required fields are marked *